<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl3">
 <label>Table 3</label>
 <caption>
  <p>Effect of ginseng on respiratory infections in human clinical trials</p>
 </caption>
 <alt-text id="alttext0030">Table 3</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Study site</th>
    <th>Disease state</th>
    <th>Parameters</th>
    <th>Ginseng (type)</th>
    <th>Dosage</th>
    <th>Results</th>
    <th>Ref</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Republic of Korea
     <break/>NCT01478009
    </td>
    <td>Influenza-like illness (ILI)</td>
    <td>(30-70 years years)
     <break/>N = 100
    </td>
    <td>KRGE</td>
    <td>9 capsules/day for 3 months</td>
    <td>Reduced ILI incidence</td>
    <td>[
     <xref rid="bib96" ref-type="bibr">96</xref>]
    </td>
   </tr>
   <tr>
    <td>Alberta, Canada</td>
    <td>Acute Respiratory infection</td>
    <td>(≥65 years)
     <break/>N = 43
    </td>
    <td>COLD-fX,</td>
    <td>Freeze-dried extract for 4 months using 2 capsules/day (200 mg/capsule)</td>
    <td>Reduced risk and duration of colds and flu.</td>
    <td>[
     <xref rid="bib97" ref-type="bibr">97</xref>]
    </td>
   </tr>
   <tr>
    <td>Edmonton, Alberta, Canada</td>
    <td>Upper respiratory infections</td>
    <td>(≥65)
     <break/>N = 783
    </td>
    <td>COLD-fX</td>
    <td>Oral extract for 6 months</td>
    <td>Safe, well tolerated, and effective as seasonal prophylaxis in duration of Jackson-confirmed URIs in healthy adults</td>
    <td>[
     <xref rid="bib98" ref-type="bibr">98</xref>]
    </td>
   </tr>
   <tr>
    <td>Edmonton, Alberta, Canada</td>
    <td>Common colds</td>
    <td>(≥18 years) N = 747</td>
    <td>(
     <italic>P. quinquefolius</italic> or 
     <italic>P. ginseng</italic>) root extract
    </td>
    <td/>
    <td>Reduced the total number and shortened the duration of ARIs by 25% and 6.2 days respectively.</td>
    <td>[
     <xref rid="bib99" ref-type="bibr">99</xref>]
    </td>
   </tr>
   <tr>
    <td>Edmonton, Alberta, Canada.</td>
    <td>Laboratory-confirmed ARI</td>
    <td>(≥60)
     <break/>N = 198
    </td>
    <td>COLD-fX</td>
    <td>200 mg capsule Oral extract twice-daily for 12 weeks</td>
    <td>LCII and RSV illness was more severe in placebo than COLD-fX-treated patients.</td>
    <td>[
     <xref rid="bib100" ref-type="bibr">100</xref>]
    </td>
   </tr>
   <tr>
    <td>Edmonton, Alberta,
     <break/>Canada
    </td>
    <td>Cold prevention</td>
    <td>(18 - 65 years)
     <break/>N = 323
    </td>
    <td>American ginseng</td>
    <td>2 capsules/day (200 mg/capsule) as freeze-dried extract capsules for 4 months</td>
    <td>Effective in reducing the absolute risk of recurrent colds and the mean number of colds per person.</td>
    <td>[
     <xref rid="bib101" ref-type="bibr">101</xref>]
    </td>
   </tr>
   <tr>
    <td>University of Alberta/Capital Health, Canada
     <break/>NCT00255307
    </td>
    <td>Upper respiratory tract Infection (URTI)</td>
    <td>(3 - 12 Years)
     <break/>N = 75
    </td>
    <td>COLD-fX,</td>
    <td>Oral aqueous solution for 6 months, adjusted to child weight</td>
    <td>Well tolerated and appropriate for short-term use in children for URTI treatment</td>
    <td>[
     <xref rid="bib102" ref-type="bibr">102</xref>]
    </td>
   </tr>
   <tr>
    <td>China (ACTRN: 12613000382774).</td>
    <td>COPD</td>
    <td>(57-73 years)
     <break/>N = 14
    </td>
    <td>
     <italic>Panax ginseng</italic> (Ren shen)
    </td>
    <td>200 mg twice daily for four weeks</td>
    <td>COPD exacerbations or adverse events</td>
    <td>[
     <xref rid="bib104" ref-type="bibr">104</xref>]
    </td>
   </tr>
   <tr>
    <td>Edmonton, Alberta, Canada NCT00965822</td>
    <td>Upper Respiratory Tract Infection</td>
    <td>(3-11 Years)
     <break/>N = 293
    </td>
    <td>COLD-fX</td>
    <td>3 day, once daily, dosing by oral route for 14 days</td>
    <td>No results</td>
    <td/>
   </tr>
   <tr>
    <td>Edmonton, Alberta, Canada
     <break/>NCT00726401
    </td>
    <td>Seasonal Allergic Rhinitis (hay fever)</td>
    <td>(12 - 75 years)
     <break/>N = 200
    </td>
    <td>COLD-fX</td>
    <td>200 mg twice daily for 4 weeks</td>
    <td>No results</td>
    <td/>
   </tr>
   <tr>
    <td>China, Hong Kong, Two General Outpatient Clinics</td>
    <td>Acute Upper Respiratory Tract Infection</td>
    <td>(≥18 Years), N = 327</td>
    <td>CHM 1. Wind-cold syndrome received treatment of Jing Fang Bai Du san
     <break/>2. Wind-heat syndrome received treatment of Ying Qiao san
    </td>
    <td>Sachets granules, Oral route at day 7</td>
    <td>Jing Fang Bai Du san relieved and effectively cleared up the pathogenic cold. Ying Qiao san effectively cleared up the pathogenic heat.</td>
    <td/>
   </tr>
   <tr>
    <td>Wake Forest University, USA
     <break/>NCT00752895
    </td>
    <td>ARI + chronic lymphocytic leukemia (CLL)</td>
    <td>(≥18 years) N = 293</td>
    <td>COLD-fX</td>
    <td>Oral extract for 3 months twice a day</td>
    <td>Profound reduction in rates of moderate-severe ARI and sore throat, suggesting increased rates of seroconversion. Enhanced antibody responses</td>
    <td>[
     <xref rid="bib109" ref-type="bibr">109</xref>]
    </td>
   </tr>
   <tr>
    <td>Italy</td>
    <td>Influenza</td>
    <td>48 years, Mean 58% males, N = 227</td>
    <td>Standardized extract of ginseng root Ginsana G 115 (114)</td>
    <td>Oral daily capsule contains 100 mg for 12 weeks</td>
    <td>NK increased two fold in the G115 group and is able to protect against common cold and influenza.</td>
    <td>[
     <xref rid="bib110" ref-type="bibr">110</xref>]
    </td>
   </tr>
   <tr>
    <td>Republic of Korea
     <break/>NCT01478009
    </td>
    <td>Acute Respiratory Illness (ARI)</td>
    <td>(30-70 years)
     <break/>N = 100
    </td>
    <td>Korean Red Ginseng Extract</td>
    <td>3 times/day, 9 capsules/day, (3g/day) for 12 weeks</td>
    <td>Effective in reducing duration and scores of ARI symptoms.</td>
    <td>[
     <xref rid="bib111" ref-type="bibr">111</xref>]
    </td>
   </tr>
   <tr>
    <td>Republic of Korea NCT03028077</td>
    <td>Acute Respiratory infection</td>
    <td>(39-65 years)
     <break/>N = 45
    </td>
    <td>1. GS-3K8 (ultra-filtered red ginseng extract)
     <break/>2. GINst15 (hydrolyzed ginseng extract)
    </td>
    <td>6 cap/day, 500 mg/cap for 8 weeks</td>
    <td>Reduced the symptoms and duration of ARI.</td>
    <td>[
     <xref rid="bib112" ref-type="bibr">112</xref>]
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>ARI, acute respiratory illness; CHM, Chinese herbal medicine; COPD, chronic obstructive pulmonary disease; LCCUs, laboratory-confirmed clinical upper respiratory infections; LCII, laboratory-confirmed influenza illness; NCT, clinical trial number; URTI, upper respiratory tract infection; KRGE, Korean Red Ginseng extract; RSV, respiratory syncytial virus</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
